Recent posts and comments

• $40.4M Blows In For First Wind

  First Wind, the Newton, MA-based developer and operator of wind farms, nabbed $40.4 million in federal financing for a planned installation at Stetson Ridge in Maine, Mass High Tech reports.... Read more »

• Pickett to Relinquish Biogen Idec Board Seat, New Financing for iWalk, Genocea Goes After Vaccine Market, & More Boston-Area Life Sciences News

  New England’s life sciences startups gave us a lot to write about last week.

  —Luke talked with Genocea Biosciences CEO Staph Bakali about his Cambridge, MA-based startup’s strategy for developing new... Read more »

• $14M for Novomer, $7.3M for Innocentive, $6M for Zendesk, & More Boston-Area Deals News

  In what I think is a first for the deals roundup, it was all venture all the time for New England’s tech and life sciences companies this past week.

  —Greentech... Read more »

• VMware Springs for SpringSource, Turbine Takes $6.7M, CombinatoRx Teams With Clinical Data, & More Boston-Area Deals News

  Boston- and Cambridge-based tech and life sciences firms cut the usual assortment of deals this week, but their brethren further out in New England were unusually active as well.

  —Marathon ... Read more »

• Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News

  This week we had the usual mix of news on partnerships, clinical trials, and the like, as well as some fascinating in-depth discussions with key players in the life sciences arena.... Read more »

• Akamai And Delve Dig Into Online Video, Cardiorobotics Snags $11.6M for Snake-Like Surgery Robot, Longworth Collects $122M, & More Boston-Area Deals News

  New England tech and life sciences firms forged several interesting new partnerships this week.

  —Apperian, a Boston-based startup developing enterprise-oriented iPhone applications, raised $1 million in a Series A... Read more »

• Genzyme Faces Lawsuit and Competition, Vertex Gathers More Cash for Telprevir, Cardiorobotics Corrals $11.6M, & More Boston-Area Life Sciences News

  Lots to report this week, and lots of it has to do with Genzyme’s manufacturing trials and tribulations.

  —An investor from Florida filed suit against Genzyme (NASDAQ:GENZ), charging that... Read more »

• Athenahealth’s Park Named HHS CTO

  Todd Park, co-founder of Watertown, MA-based Athenahealth (NASDAQ: ATHN) and San Mateo, CA-based Maria Health, has been tapped to serve as chief technology officer of the U.S. Department of... Read more »

• FDA to Re-inspect Genzyme Plant

  Cambridge, MA-based Genzyme (NASDAQ: GENZ) announced today that the FDA will re-inspect the biotech giant’s Allston manufacturing facility, which was closed in June after a viral contaminant was spotted.... Read more »

• Commenting on: Seattle’s Lifestyle Keeps Us Trailing the Bay Area, Says UW Startup Maven Janis Machala

  Rebecca said: Hi Dave, Luke did not remove your comment, it was just caught in our spam filter (likely because it had very... Read more »

• Vertex Scores $105M For Asian Telaprevir Rights, Avila Avails Itself of $30M, IBM Picks Up Ounce Labs, & More Boston-Area Deals News

  Is it just me, or is the roundup of New England technology and life sciences deals news getting a little longer each week?

  —Matrix Partners of Waltham, MA, reportedly raised... Read more »

• Joule Debuts Biofuel Technology, Genzyme Cleans House, Avila Banks $30M, & More Boston-Area Life Sciences News

  New England’s life sciences companies gave us a number of cool new technologies and interesting deals to talk about this week.

  —Cambridge, MA-based Genzyme (NASDAQ: GENZ) finished cleaning up its... Read more »

• $8M More for Acquia, Novartis-Alnylam Collaboration Continues, Virtualization Firm Akiba Acquires $6.53M, & More Boston-Area Deals News

  I’ve got a nice variety of deals—particularly venture financings—to tell you about this week.

  —Swiss drug giant Novartis opted to extend a collaboration with Alnylam Pharmaceuticals (NASDAQ:ALNY) of Cambridge,... Read more »

• Xconomy Boston Is On The (Very Short) Move

  Posting will be light from Xconomy Boston today, as we’re busy hauling our stuff three blocks down Rogers Street to our new headquarters at 101 Rogers Street. That’s right, we’re moving... Read more »

• $50M for ConforMIS, $8.2M for ConnectEDU, $7.25M for MedVentive, & More Boston-Area Deals News

  I’m happy to say that the last week has provided a number of venture financings to talk about, and a few other deals as well.

  —Waltham, MA-based North Bridge Venture Partners... Read more »

• ConforMIS Corrals $50M, Oscient Files for Bankruptcy, Vertex Peddles Rights to Milestone Payments, & More Boston-Area Life Sciences News

  New England’s life sciences companies produced a couple of sizeable venture deals this past week, but they also faced some significant challenges.

  —Rapid Micro Biosystems closed a Series A financing... Read more »

• EMC Prevails in Data Domain Bidding War, New Funds for Excel and 5AM, Sonian Sees $4.1M, & More Boston-Area Deals News

  There’s not one but two venture-fund closings to report this week. More below on those, and the rest of the week’s deals news from New England’s life science and tech firms.... Read more »

• Biogen Idec Buys MS Drug Rights, Immuneering Models Cancer Drug Responses, Hologic Wins Contraceptive Device Approval, & More Boston-Area Life Sciences News

  Perhaps New England’s life sciences companies were busy building arks this past week, because the news flow was a heck of a lot lighter than the rainfall. There are still a... Read more »

• Hologic Device Approved by FDA

  Bedford, MA-based Hologic (NASDAQ: HOLX) announced that the FDA has approved its permanent contraception device, called Adiana. Offering a less-invasive alternative to tubal ligation—a surgical procedure that is one of... Read more »

• LogMeIn Pulls Off a $107 million IPO, CombinatoRx To Pair With Neuromed, CloudSwitch Turns on $8M, & More Boston-Area Deals News

  Finally, an IPO! That, and the rest of the week’s deals news from New England’s tech and life sciences industries below.

  —Lexington, MA-based Highland Capital Partners reportedly pushed the close of... Read more »